Source BioScience UK Ltd, a provider of genomic services and histopathology diagnostics, has completed its acquisition of Cambridge Clinical Laboratories (CCL), a provider of clinical, personalized healthcare testing services. The acquisition bolsters Source’s clinical diagnostics portfolio by leveraging the expertise of the CCL team and new clinical lab facilities at Vision Park in Cambridge, providing streamlined testing services for both preclinical and clinical research. CCL provides p...